Covid-19: Scientists find antibodies effective against all variants

Covid-19: Scientists find antibodies effective against all variants


The research also revealed that hybrid immunity provides superior antibody-based protection against future exposure to the virus.




Scientists have identified an antibody capable of neutralizing all known variants of Sars-CoV-2, the virus responsible for Covid-19. Called SC27, the antibody was discovered and isolated from a single patient by a group of researchers led by the University of Texas at Austin. The details of the discovery were published in the journal Medicine of cellular relationships.

As part of a study on hybrid immunity – which results from the combination of infection and vaccination – the team managed to isolate the SC27 antibody using advanced technologies developed over years of research. Obtaining the precise molecular sequence of the antibody opens the possibility of its large-scale production for future treatments.

β€œThe future discovery of SC27 and similar antibodies will help protect the population from current and future variants of Covid.”

Symptoms of Covid, Flu and Sinusitis: What's the Difference?
Symptoms of Covid, Flu and Sinusitis: What’s the Difference?

Since its identification, Sars-CoV-2 has evolved rapidly, becoming resistant to vaccines and treatments developed to date. The goal of current research is to create a universal vaccine capable of generating antibodies and a broad immune response, offering protection against the virus and its mutations.

The SC27 antibody works by binding to the virus’s spike protein, a structure essential for infecting human cells. By blocking this protein, the antibody prevents infection.

In addition to identifying the antibody, the research found that hybrid immunity provides superior antibody-based protection against future exposure to the virus, compared to protection obtained from infection or vaccination alone.

To isolate SC27, the researchers used Ig-Seq technology, which combines single-cell DNA sequencing with proteomic analysis. This technology provides detailed insight into the antibody response to both infection and vaccination.

Source: Terra

You may also like